Industrialisation des thérapies décentralisées : Biosécurité de l'oncologie personnalisée à ARNm (Déclaration d'antériorité / Prior Art)

Abstract

Résumé FRCe document, produit avec l’assistance de Gemini 3 Raisonnement, est publié sous Licence Apache 2.0. Il constitue une publication défensive (antériorité) volontaire et entre de ce fait dans l’état de la technique au sens des législations applicables : (EPC Art. 54(2); French IPC Art. L 611-11; cf. 35 U.S.C. §102(a)). Ce rapport technique décrit de manière exhaustive une plateforme décentralisée de thérapie génique. Il présente 32 inventions actionnables incluant le séquençage au point de soin, la synthèse microfluidique d'ARNm, la formulation de nanoparticules lipidiques (LNP), le DRM biologique cryptographique sur blockchain et la gestion verte des effluents. Chaque proposition est documentée de façon à permettre sa reproduction, associée à des codes CIB/CPC, et horodatée afin d'empêcher tout blocage par brevet ultérieur. Abstract ENThis document, produced with the assistance of Gemini 3 Reasoning, is released under the Apache 2.0 licence. It is a voluntary defensive publication (prior art) and therefore enters the prior art upon release under the applicable patent statutes: (art. L 611-11 CPI / art. 54(2) CBE). This publication describes an exhaustive, end-to-end decentralized genetic therapy platform. It discloses 32 enabling inventions spanning point-of-care sequencing, automated microfluidic synthesis, lipid nanoparticle (LNP) formulation, cryptographic biological DRM via TPM 2.0/blockchain, and green disposal units. Each innovation is described with detailed specifications to enable reproduction, designated with plausible IPC/CPC codes, and timestamped (RFC 3161) to preempt subsequent offensive patent filings by third parties globally, securing a shared open-access commons for personalized mRNA medicine. Timestamp: 2026-07-16T19:23:26ZSHA-256: 83c64589fce322d8c32e5ff9fbcf93506c38f5e9d0b5eff49add04a886be9706 Liste des innovations & classification (IPC ; CPC)#1 Integrated microfluidic nanopore sequencer (IPC B01L 3/00 ; CPC B01L 3/5027)#2 Multiplexed MHC haplotyping kit (IPC C12Q 1/6886 ; CPC C12Q 1/6886)#3 Hybrid cloud-edge MHC docking pipeline (IPC G16H 50/20 ; CPC G16H 50/20)#4 Closed-loop mRNA dosing scheduler (IPC G16H 20/17 ; CPC G16H 20/17)#5 Optimized SM-102 LNP formulation (IPC A61K 9/127 ; CPC A61K 9/1272)#6 Automated microfluidic chip clean-in-place (IPC B01L 99/00 ; CPC B01L 2200/10)#7 LNP biodistribution imaging reconstruction (IPC A61B 5/00 ; CPC A61B 5/4848)#8 Dissolvable microneedle patch for LNPs (IPC A61K 9/00 ; CPC A61K 9/0021)#9 Synchronized mRNA and anti-PD-1 co-therapy (IPC A61K 39/00 ; CPC A61K 39/0011)#10 Privacy-preserving federated antigen learning (IPC G06F 21/62 ; CPC G06F 21/6245)#11 Cryptographic DRM biological synthesizer (IPC G06F 21/44 ; CPC G06F 21/44)#12 Smart IoT cold chain container (IPC F25D 29/00 ; CPC F25D 29/003)#13 Cloud-based microfluidic calibration service (IPC G05B 19/418 ; CPC G05B 19/4183)#14 Segmented Poly(A) expression cassette (IPC C12N 15/67 ; CPC C12N 15/67)#15 On-chip chromatographic dsRNA purification (IPC B01D 15/34 ; CPC B01D 15/345)#16 Multi-species dynamic codon optimizer (IPC G16B 25/10 ; CPC G16B 25/10)#17 Smart sensor-enabled reagent cartridge (IPC G01N 27/02 ; CPC G01N 27/02)#18 LAMP1 lysosomal-targeting mRNA chimera (IPC C12N 15/62 ; CPC C12N 15/62)#19 Automated lipid effluent inactivation module (IPC B01D 21/00 ; CPC C02F 1/02)#20 Function-based biosecurity screening AI (IPC G16B 40/00 ; CPC G06N 3/08)#21 Direct RNA-pore sequencing for haplotyping (IPC C12Q 1/6869 ; CPC C12Q 1/6869)#22 Enzymatic long DNA template assembly (IPC C12N 15/10 ; CPC C12N 15/10)#23 Microfluidic full-substitution IVT bioreactor (IPC C12P 19/34 ; CPC C12P 19/34)#24 Asymmetric staggered herringbone mixer (IPC B01F 33/30 ; CPC B01F 33/30)#25 Refractometer-controlled active micro-dialyser (IPC B01D 61/14 ; CPC B01D 61/14)#26 Edge-distributed semantic genomic cache (IPC G16B 50/00 ; CPC G16B 50/00)#27 Unified memory CUDA orchestration for AF3 (IPC G06F 12/02 ; CPC G06F 12/02)#28 Coordinated structural neoantigen selector (IPC G16B 15/00 ; CPC G16B 15/30)#29 Blockchain biosecurity validation consensus (IPC H04L 9/32 ; CPC H04L 9/3239)#30 Clinical MLOps regulatory continuous auditor (IPC G06N 20/00 ; CPC G06N 20/00)#31 Lyophilized multi-lipid argon-sealed mix (IPC A61K 47/54 ; CPC A61K 47/54)#32 Benchtop microwave pyrolysis waste neutralizer (IPC A61L 11/00 ; CPC A61L 11/00) Keywordsnanopore sequencing, microfluidic cartridge, point-of-care diagnostics, MHC haplotyping, long-read sequencing, cancer neoantigens, hybrid cloud-edge, structural biology, neoantigen prediction, closed-loop dosing, ctDNA monitoring, personalized immunotherapy, lipid nanoparticles, SM-102, messenger RNA delivery, clean-in-place, microfluidic chip, cross-contamination prevention, fluorescence imaging, deep learning reconstruction, LNP biodistribution, microneedle patch, transdermal delivery, mRNA vaccine, combination immunotherapy, neoantigen vaccine, anti-PD-1 antibody, federated learning, homomorphic encryption, genomic privacy, biological DRM, blockchain consensus, hardware-bound security, cold chain logistics, IoT thermal monitoring, self-destruct security, calibration-as-a-service, dynamic light scattering, microfluidic tuning, segmented polyA, enzymatic synthesis, mRNA stability, dsRNA purification, microfluidic chromatography, in vitro transcription, codon optimization, expression cassette, comparative oncology, reagent cartridge, lipid stability, quality control sensor, lysosomal targeting, tPA signal peptide, MHC class II presentation, waste inactivation, lipid nanoparticle disposal, ecotoxicity prevention, functional biosecurity, deep learning screening, sequence evasion, direct RNA sequencing, nanopore basecalling, enzymatic DNA synthesis, template assembly, plasmid-free IVT, staggered herringbone mixer, microfluidic shear, lipid nanoparticle formulation, tangential flow filtration, solvent extraction, closed-loop dialysis, genomic sequence cache, sequence alignment, edge computing, unified memory CUDA, structural inference, edge hardware optimization, neoantigen selection, pLDDT score, molecular docking filter, biosecurity consensus, smart contract, DNA synthesis authorization, MLOps, software certification, clinical AI drift, lipid mix cartridge, SM-102 stability, clinical reagents, waste neutralizer, microwave pyrolysis, biohazardous waste disposal